Commentary: Copper and cuproptosis-related genes in hepatocellular carcinoma: therapeutic biomarkers targeting tumor immune microenvironment and immune checkpoints

Bibliographic Details
Main Authors: Fangshi Xu, Danrui Cai, Zheng Yang, Jian Yin, Yi Sun
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1265565/full
_version_ 1797737004928073728
author Fangshi Xu
Danrui Cai
Zheng Yang
Jian Yin
Yi Sun
author_facet Fangshi Xu
Danrui Cai
Zheng Yang
Jian Yin
Yi Sun
author_sort Fangshi Xu
collection DOAJ
first_indexed 2024-03-12T13:21:11Z
format Article
id doaj.art-3774c8e58c0a4325877b13a9ff7a80d5
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-03-12T13:21:11Z
publishDate 2023-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-3774c8e58c0a4325877b13a9ff7a80d52023-08-25T18:24:07ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-08-011410.3389/fimmu.2023.12655651265565Commentary: Copper and cuproptosis-related genes in hepatocellular carcinoma: therapeutic biomarkers targeting tumor immune microenvironment and immune checkpointsFangshi Xu0Danrui Cai1Zheng Yang2Jian Yin3Yi Sun4Department of Urology, Shaanxi Provincial People’s Hospital, Xi’an, Shaanxi, ChinaDepartment of Ophthalmology, Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, ChinaDepartment of Urology, Shaanxi Provincial People’s Hospital, Xi’an, Shaanxi, ChinaDepartment of Urology, Shaanxi Provincial People’s Hospital, Xi’an, Shaanxi, ChinaDepartment of Urology, Shaanxi Provincial People’s Hospital, Xi’an, Shaanxi, Chinahttps://www.frontiersin.org/articles/10.3389/fimmu.2023.1265565/fullcuproptosiscancerpathogenesisbioinformaticssignature
spellingShingle Fangshi Xu
Danrui Cai
Zheng Yang
Jian Yin
Yi Sun
Commentary: Copper and cuproptosis-related genes in hepatocellular carcinoma: therapeutic biomarkers targeting tumor immune microenvironment and immune checkpoints
Frontiers in Immunology
cuproptosis
cancer
pathogenesis
bioinformatics
signature
title Commentary: Copper and cuproptosis-related genes in hepatocellular carcinoma: therapeutic biomarkers targeting tumor immune microenvironment and immune checkpoints
title_full Commentary: Copper and cuproptosis-related genes in hepatocellular carcinoma: therapeutic biomarkers targeting tumor immune microenvironment and immune checkpoints
title_fullStr Commentary: Copper and cuproptosis-related genes in hepatocellular carcinoma: therapeutic biomarkers targeting tumor immune microenvironment and immune checkpoints
title_full_unstemmed Commentary: Copper and cuproptosis-related genes in hepatocellular carcinoma: therapeutic biomarkers targeting tumor immune microenvironment and immune checkpoints
title_short Commentary: Copper and cuproptosis-related genes in hepatocellular carcinoma: therapeutic biomarkers targeting tumor immune microenvironment and immune checkpoints
title_sort commentary copper and cuproptosis related genes in hepatocellular carcinoma therapeutic biomarkers targeting tumor immune microenvironment and immune checkpoints
topic cuproptosis
cancer
pathogenesis
bioinformatics
signature
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1265565/full
work_keys_str_mv AT fangshixu commentarycopperandcuproptosisrelatedgenesinhepatocellularcarcinomatherapeuticbiomarkerstargetingtumorimmunemicroenvironmentandimmunecheckpoints
AT danruicai commentarycopperandcuproptosisrelatedgenesinhepatocellularcarcinomatherapeuticbiomarkerstargetingtumorimmunemicroenvironmentandimmunecheckpoints
AT zhengyang commentarycopperandcuproptosisrelatedgenesinhepatocellularcarcinomatherapeuticbiomarkerstargetingtumorimmunemicroenvironmentandimmunecheckpoints
AT jianyin commentarycopperandcuproptosisrelatedgenesinhepatocellularcarcinomatherapeuticbiomarkerstargetingtumorimmunemicroenvironmentandimmunecheckpoints
AT yisun commentarycopperandcuproptosisrelatedgenesinhepatocellularcarcinomatherapeuticbiomarkerstargetingtumorimmunemicroenvironmentandimmunecheckpoints